Timothy Springer, a biotech founder, investor, and professor at Harvard Medical School, discusses the evolution, therapeutic applications, and future innovations of antibodies with Forbes Senior Editor Alex Knapp. Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1 Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at